Our View - Issue V, December 2014
China’s healthcare industry is facing inevitable change as it seeks to attract more foreign investment and encourage privatization of some public health facilities and services. In this issue, we outline the various reforms underway and how private capital is being used as an antidote to the nation’s overburdened healthcare system, in addition to the various options for investors.
© 2020 KPMG Huazhen LLP, a People's Republic of China partnership, KPMG Advisory (China) Limited, a limited liability company in China, KPMG, a Macau partnership and KPMG, a Hong Kong partnership, are member firms of the KPMG global organisation of independent member firms affiliated with KPMG International Limited ("KPMG International"), a private English company limited by guarantee. All rights reserved. The KPMG name and logo are registered trademarks or trademarks of KPMG International.
For more detail about the structure of the KPMG global organisation please visit https://home.kpmg/governance.